NO851535L - Nye polypeptider med blodkoaguleringshemmende virkning, fremgangsmaate til deres fremstilling resp. utvinnelse, deres anvendelse og midler inneholdende disse - Google Patents

Nye polypeptider med blodkoaguleringshemmende virkning, fremgangsmaate til deres fremstilling resp. utvinnelse, deres anvendelse og midler inneholdende disse

Info

Publication number
NO851535L
NO851535L NO851535A NO851535A NO851535L NO 851535 L NO851535 L NO 851535L NO 851535 A NO851535 A NO 851535A NO 851535 A NO851535 A NO 851535A NO 851535 L NO851535 L NO 851535L
Authority
NO
Norway
Prior art keywords
polypeptide
val
formula
peptide
acid
Prior art date
Application number
NO851535A
Other languages
English (en)
Norwegian (no)
Inventor
Dominique Tripier
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO851535L publication Critical patent/NO851535L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO851535A 1984-04-18 1985-04-17 Nye polypeptider med blodkoaguleringshemmende virkning, fremgangsmaate til deres fremstilling resp. utvinnelse, deres anvendelse og midler inneholdende disse NO851535L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3414593 1984-04-18
DE19843438296 DE3438296A1 (de) 1984-04-18 1984-10-19 Neue polypeptide mit blutgerinnungshemmender wirkung, verfahren zu deren herstellung bzw. gewinnung, deren verwendung und diese enthaltende mittel

Publications (1)

Publication Number Publication Date
NO851535L true NO851535L (no) 1985-10-21

Family

ID=25820510

Family Applications (1)

Application Number Title Priority Date Filing Date
NO851535A NO851535L (no) 1984-04-18 1985-04-17 Nye polypeptider med blodkoaguleringshemmende virkning, fremgangsmaate til deres fremstilling resp. utvinnelse, deres anvendelse og midler inneholdende disse

Country Status (18)

Country Link
US (1) US4668662A (OSRAM)
EP (1) EP0158986B1 (OSRAM)
JP (1) JP2552263B2 (OSRAM)
KR (1) KR930000054B1 (OSRAM)
AR (1) AR242800A1 (OSRAM)
AU (1) AU580295B2 (OSRAM)
CA (1) CA1271298A (OSRAM)
DE (2) DE3438296A1 (OSRAM)
DK (1) DK171824B1 (OSRAM)
ES (3) ES8605770A1 (OSRAM)
FI (1) FI851521L (OSRAM)
GR (1) GR850942B (OSRAM)
HU (1) HU198085B (OSRAM)
IE (1) IE60581B1 (OSRAM)
IL (1) IL74948A (OSRAM)
NO (1) NO851535L (OSRAM)
PT (1) PT80301B (OSRAM)
ZA (1) ZA852854B (OSRAM)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
DE3583361D1 (de) * 1984-06-14 1991-08-08 Ucp Gen Pharma Ag Verfahren zur herstellung von thrombin-inhibitoren.
DE3506992A1 (de) * 1985-02-27 1986-08-28 Plantorgan Werk Heinrich G.E. Christensen, KG, 2903 Bad Zwischenahn Modifizierte hirudine, verfahren zu deren herstellung und pharmazeutische mittel, die diese wirkstoffe enthalten
DE3738541A1 (de) * 1987-11-13 1989-05-24 Hoechst Ag Verfahren zur isolierung und reinigung von hirudin
IL88925A (en) * 1985-04-11 1995-11-27 Hoechst Ag Hirudin derivative and pharmaceutical composition containing same
EP0209061B1 (de) * 1985-07-17 1994-01-12 Hoechst Aktiengesellschaft Neue Polypeptide mit blutgerinnungshemmender Wirkung, Verfahren zu deren Herstellung bzw. Gewinnung, deren Verwendung und diese enthaltende Mittel
GB8530631D0 (en) 1985-12-12 1986-01-22 Ciba Geigy Ag Thrombin inhibitors
US6005071A (en) * 1987-01-23 1999-12-21 Merrell Pharmaceuticals Inc. Anticoagulant peptides
US5789540A (en) * 1987-01-23 1998-08-04 Merrell Pharmaceuticals Inc. Anticoagulant peptides
PT87083B (pt) * 1987-03-28 1992-07-31 Boehringer Ingelheim Int Processo para a preparacao de uma proteina anticoagulante vascular, de adn que codifica para esta proteina e de composicoes farmaceuticas que a contem
US5236898A (en) * 1987-05-21 1993-08-17 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5192745A (en) * 1987-05-21 1993-03-09 Merrell Dow Pharmaceuticals Inc. Cyclic anticoagulant peptides
US5256559A (en) * 1988-03-04 1993-10-26 Biogen, Inc. Methods and compositions for inhibiting platelet aggregation
US4971953A (en) * 1988-05-10 1990-11-20 Merrell Dow Pharmaceuticals Anticoagulant peptide alcohols
NZ228995A (en) * 1988-05-10 1992-03-26 Merrell Dow Pharma Hirudin peptide derivatives and pharmaceutical compositions
US5114921A (en) * 1988-05-27 1992-05-19 The Children's Hospital Of Philadelphia Amphiphilic peptides and use thereof
BR8907452A (pt) * 1988-05-27 1991-04-02 Magainin Sciences Inc Peptideo e polipeptideo antifilicos,processo e composicao para sua utilizacao
DE3819078A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Amblyommin, ein neuer wirkstoff fuer die antikoagulationstherapie
DE3819079A1 (de) * 1988-06-04 1989-12-07 Hoechst Ag Hirudin-derivate mit verzoegerter wirkung
EP0347376B1 (en) * 1988-06-11 1994-03-23 Ciba-Geigy Ag Novel polypeptides with an anticoagulant activity
US5268296A (en) * 1988-06-11 1993-12-07 Ciba-Geigy Corporation DNA vector and recombinant host cell for production of hirullin P6 and P18
US5112615A (en) * 1988-08-03 1992-05-12 New England Deaconess Hospital Corporation Soluble hirudin conjugates
US5167960A (en) * 1988-08-03 1992-12-01 New England Deaconess Hospital Corporation Hirudin-coated biocompatible substance
DE3835815A1 (de) * 1988-10-21 1990-04-26 Hoechst Ag Neue isohirudine
US4861865A (en) * 1989-01-23 1989-08-29 Washington University Novel antithrombin peptide
US5254535A (en) * 1989-04-17 1993-10-19 The Children's Hospital Of Pennsylvania Composition and treatment with biologically active peptides and antibiotic
US5179196A (en) * 1989-05-04 1993-01-12 Sri International Purification of proteins employing ctap-iii fusions
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
DE3939801A1 (de) * 1989-12-01 1991-06-06 Basf Ag Neue proteine und ihre herstellung
US5792831A (en) * 1990-02-08 1998-08-11 Magainin Pharmaceuticals Inc. Analogues of magainin peptides containing D-amino acids
US5459237A (en) * 1990-02-08 1995-10-17 Magainin Pharmaceuticals Inc. Peptide compositions and uses therefor
EP0514464A4 (en) * 1990-02-08 1993-04-28 Magainin Sciences, Inc. Biologically active amphiphilic peptides and method of inhibiting growth of target cells, virus or virally-infected cell
AU641215B2 (en) * 1990-02-13 1993-09-16 Merrell Dow Pharmaceuticals Inc. Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin
DE4009268A1 (de) * 1990-03-22 1991-09-26 Consortium Elektrochem Ind Sekretion von hirudinderivaten
WO1991017760A1 (en) * 1990-05-14 1991-11-28 Magainin Sciences Inc. Composition of and treatment with biologically active peptides having d-amino acid residues
EP0559647A1 (en) * 1990-06-27 1993-09-15 Magainin Pharmaceuticals Inc. Composition and treatment with biologically active peptides and antibiotics which inhibit dna gyrase
US5208220A (en) * 1990-06-27 1993-05-04 Magainin Pharmaceuticals, Inc. Composition and treatment with biologically active peptides and antibiotics which inhibit DNA gyrase
US5574012A (en) * 1990-07-24 1996-11-12 Merrell Pharmaceuticals Inc. Analogs of hirudin having anti-platelet activity
US5118790A (en) * 1990-07-24 1992-06-02 Sri International Analogs of hirudin
AU648096B2 (en) * 1990-07-24 1994-04-14 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
US6514730B1 (en) * 1991-03-21 2003-02-04 Consortium für elektrochemische Industrie GmbH Secretion of hirudin derivatives
WO1993007892A1 (en) * 1991-10-16 1993-04-29 The Children's Hospital Of Philadelphia Composition and treatment with biologically active peptides and antibiotic
DE4140381A1 (de) * 1991-12-07 1993-06-09 Hoechst Ag, 6230 Frankfurt, De Neue synthetische isohirudine mit verbesserter stabilitaet
CA2164712C (en) * 1993-06-11 2000-03-28 Robert J. Broersma, Jr. Trifunctional antithrombin and antiplatelet peptides
NZ270194A (en) * 1994-01-07 1996-05-28 Ciba Geigy Ag Hirustasin, a serine protease inhibitor from hirudo medicinalis
GB9401447D0 (en) 1994-01-26 1994-03-23 Ciba Geigy Ag Pharmaceutical compositions
DE4404168A1 (de) * 1994-02-10 1995-08-17 Hoechst Ag Hirudinderivate und Verfahren zu deren Herstellung
DE19529997C1 (de) 1995-08-16 1997-04-10 Hoechst Ag Verfahren zur Inaktivierung von Carboxypeptidase Y in hirudinhaltigen Kulturbrühen
DE19543737A1 (de) * 1995-11-24 1997-05-28 Hoechst Ag Verfahren zur Ultrafiltration von Peptide oder Proteine enthaltender biologischer Matrices
DE19544233A1 (de) 1995-11-28 1997-06-05 Hoechst Ag Verfahren zur Nutzung des Hefe-ADH II-Promotorsystems zur biotechnologischen Produktion heterologer Proteine in hohen Ausbeuten
DE69625623T2 (de) 1996-01-31 2003-11-06 Sumitomo Bakelite Co. Ltd., Tokio/Tokyo Verfahren zur Herstellung von in Epoxyharz eingekapselter Halbleitervorrichtung
DE19607239A1 (de) 1996-02-27 1997-08-28 Behringwerke Ag Pharmazeutische Zusammensetzung, enthaltend Hirudin und Verfahren zu deren Herstellung
US7795205B2 (en) 2004-04-12 2010-09-14 Canyon Pharmaceuticals, Inc. Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor
CN101095697A (zh) * 2006-06-28 2008-01-02 李振国 水蛭和/或地龙分子量5800道尔顿以下的提取物
US9056118B2 (en) * 2007-06-26 2015-06-16 Mudanjiang Youbo Pharmaceutical Co., Ltd. Extract for preventing of treating thrombotic diseases
SG171340A1 (en) * 2008-11-19 2011-07-28 Avantor Performance Mat Inc New chromatographic media based on phenoxy alkyl and alkoxy-or phenoxy-phenyl alkyl ligands

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3342139A1 (de) * 1983-11-22 1985-05-30 Ciba-Geigy Ag, Basel Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel
ATE78294T1 (de) * 1984-03-27 1992-08-15 Transgene Sa Expressionsvektoren fuer hirudin, transformierte zellen und verfahren zur herstellung von hirudin.
DE3429430A1 (de) * 1984-08-10 1986-02-20 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens

Also Published As

Publication number Publication date
DK173985A (da) 1985-10-19
ES8605772A1 (es) 1985-12-16
ES542311A0 (es) 1985-12-16
FI851521A7 (fi) 1985-10-19
DE3587576D1 (de) 1993-10-21
IE60581B1 (en) 1994-07-27
EP0158986A2 (de) 1985-10-23
AR242800A1 (es) 1993-05-31
PT80301A (de) 1985-05-01
IL74948A (en) 1989-09-10
DK171824B1 (da) 1997-06-23
KR930000054B1 (ko) 1993-01-06
AU580295B2 (en) 1989-01-12
ES542309A0 (es) 1985-12-16
CA1271298A (en) 1990-07-03
US4668662A (en) 1987-05-26
KR850007801A (ko) 1985-12-09
ES542310A0 (es) 1985-12-16
JP2552263B2 (ja) 1996-11-06
ES8605770A1 (es) 1985-12-16
HUT37806A (en) 1986-02-28
HU198085B (en) 1989-07-28
ZA852854B (en) 1985-11-27
DE3438296A1 (de) 1985-11-07
EP0158986A3 (en) 1988-09-21
GR850942B (OSRAM) 1985-11-25
EP0158986B1 (de) 1993-09-15
IE850983L (en) 1985-10-18
AU4136485A (en) 1985-10-24
JPS60233098A (ja) 1985-11-19
FI851521A0 (fi) 1985-04-16
PT80301B (de) 1987-02-10
DK173985D0 (da) 1985-04-17
IL74948A0 (en) 1985-08-30
ES8605771A1 (es) 1985-12-16
FI851521L (fi) 1985-10-19

Similar Documents

Publication Publication Date Title
NO851535L (no) Nye polypeptider med blodkoaguleringshemmende virkning, fremgangsmaate til deres fremstilling resp. utvinnelse, deres anvendelse og midler inneholdende disse
DK173509B1 (da) Polypeptider med blodkoaguleringshæmmende virkning, deres fremstilling eller udvinding samt midler med indhold deraf
CA1239606A (en) Desulfatohirudins, the preparation thereof and pharmaceutical compositions containing them
Charles et al. The primary structure of porcine colipase II. I. The amino acid sequence
EP0147193B1 (en) Peptide production and use thereof
US4003884A (en) Peptides having LH-RH/FSH-RH activity
RU2050160C1 (ru) Полипептид, полученный из ткани или секрета пиявок hirudinaria manillensis, специфически ингибирующий тромбин
US4656158A (en) Peptide, and production and use thereof
CA1137467A (en) Process for the preparation of somatostatin
IE59400B1 (en) Peptide amino-alcohol derivatives containing a tetra-substituted carbon atom, inhibitors of renin and of acid preteases, preparation process and pharmaceutical compositions.
LU85710A1 (fr) Nouveaux derives de la gonadoliberine et procede pour leur preparation
Akaji et al. Efficient synthesis of peptaibol using a chloroimidazolidium coupling reagent, CIP
CA1249396A (en) Partially retro-inverted decapeptide as a specific renin inhibitor with high resistance to enzymatic hydrolysis
PL111979B1 (en) Process for preparing novel peptides
RU2086561C1 (ru) Способ получения нонапептидэтиламида
US4784988A (en) Peptides correlated to lysozyme
Bentley et al. 1176. Polypeptides. Part I. The synthesis of peptides related to eledoisin
UEDA et al. Synthesis of the hexadecapeptide corresponding to positions 1 through 16 of porcine motilin, a gastric motor activity stimulating polypeptide
Katsoyannis et al. Insulin peptides. XVIII. Synthesis of a partially protected heneicosapeptide containing the C-terminal sequence of the B chain of insulin
Beddell et al. Pseudosymmetry in the structure of luteinizing hormone-releasing hormone. Series of novel analogs
JPH05331190A (ja) 新規ペプチド及びその製造方法
TSUBOI et al. Amino Acids and Peptide. XXX. Synthesis of Eglin c (41-49) and Eglin c (60-63) and Examination of Their Inhibitory Activity towards Human Leukocyte Elastase, Cathepsin G, Porcine Pancreatic Elastase and α-Chymotrypsin
JPH08333389A (ja) ヘキサペプチドの製造方法
Abiko et al. Synthesis of [Phe (4F) 3] thymopoietin II and examination of its immunological effect on the impaired blastogenic response of T-lymphocytes of uremic patients
JPH0959296A (ja) 新規なテトラペプチドおよびアンジオテンシン変換酵素 阻害剤